We are live on ! Find out more
DC

Defender Capital Portfolio holdings

AUM $308M
1-Year Est. Return 4.52%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+4.52%
3 Year Est. Return
+83.48%
5 Year Est. Return
+78.82%
10 Year Est. Return
AUM
$286M
AUM Growth
+$38.8M
Cap. Flow
+$18.8M
Cap. Flow %
6.57%
Top 10 Hldgs %
91.87%
Holding
40
New
7
Increased
13
Reduced
7
Closed
1

Top Sells

Rank Stock Value
1
AXON
Axon Enterprise
AXON
+$5.01M
2
TDY icon
Teledyne Technologies
TDY
+$663K
3
STAA icon
STAAR Surgical
STAA
+$625K
4
ESAB icon
ESAB
ESAB
+$363K
5
COST icon
Costco
COST
+$83.4K

Sector Composition

Rank Sector Weight
1 Healthcare 27.32%
2 Technology 17.31%
3 Financials 14.57%
4 Consumer Staples 9.44%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGSH icon
1
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$64.6M 22.57%
1,104,170
+259,260
+31% +$15.1M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.06T
$41.2M 14.4%
133,583
+6,365
+5% +$1.96M
DHR icon
3
Danaher
DHR
$142B
$36M 12.56%
160,964
+6,360
+4% +$1.45M
STAA icon
4
STAAR Surgical
STAA
$1.19B
$31.4M 10.98%
491,497
-9,574
-2% -$625K
FTV icon
5
Fortive
FTV
$18.6B
$25.9M 9.03%
503,591
+6,696
+1% +$337K
MNST icon
6
Monster Beverage
MNST
$93.4B
$18.5M 6.46%
342,580
+37,304
+12% +$1.91M
TDY icon
7
Teledyne Technologies
TDY
$29B
$15.3M 5.33%
34,092
-1,565
-4% -$663K
AXON
8
Axon Enterprise
AXON
$42.5B
$14.2M 4.96%
63,147
-25,180
-29% -$5.01M
COST icon
9
Costco
COST
$415B
$8.26M 2.88%
16,625
-170
-1% -$83.4K
LCTX icon
10
Lineage Cell Therapeutics
LCTX
$274M
$7.7M 2.69%
5,136,085
+42,550
+0.8% +$59.4K
BE icon
11
Bloom Energy
BE
$56.1B
$3.05M 1.06%
152,800
-400
-0.3% -$8.76K
INTC icon
12
Intel
INTC
$488B
$2.77M 0.97%
84,815
+7,700
+10% +$218K
PLTR icon
13
Palantir
PLTR
$323B
$2.74M 0.96%
324,330
+39,890
+14% +$312K
ESAB icon
14
ESAB
ESAB
$5.16B
$2.25M 0.78%
38,023
-6,338
-14% -$363K
AAPL icon
15
Apple
AAPL
$4.8T
$1.18M 0.41%
7,182
+829
+13% +$122K
CVX icon
16
Chevron
CVX
$378B
$1.14M 0.4%
+7,000
New +$1.17M
MSFT icon
17
Microsoft
MSFT
$2.99T
$974K 0.34%
3,379
+1,414
+72% +$361K
ANIP icon
18
ANI Pharmaceuticals
ANIP
$1.77B
$953K 0.33%
24,000
IMDX
19
Insight Molecular Diagnostics
IMDX
$156M
$838K 0.29%
118,172
+4,525
+4% +$33.6K
ENOV icon
20
Enovis
ENOV
$1.54B
$802K 0.28%
+15,000
New +$869K
GOOGL icon
21
Alphabet (Google) Class A
GOOGL
$4.3T
$605K 0.21%
5,830
+25
+0.4% +$2.4K
CBRL icon
22
Cracker Barrel
CBRL
$1.19B
$570K 0.2%
5,020
INFL icon
23
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.47B
$561K 0.2%
+18,200
New +$568K
NVDA icon
24
NVIDIA
NVDA
$4.92T
$556K 0.19%
+20,000
New +$433K
IWM icon
25
iShares Russell 2000 ETF
IWM
$81.2B
$553K 0.19%
3,100

Similar funds

Defender Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Defender Capital held 40 positions worth $286M, up 16% from $248M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Defender Capital deployed $18.8M of net new capital in Q1 2023, opening 7 new positions and adding to 13 existing holdings. Its largest new stake was Chevron: 7,000 shares worth $1.14M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $5.01M trimmed.

  • Defender Capital's largest Q1 2023 buy was Chevron: 7,000 shares worth $1.14M.
  • Defender Capital added most to Vanguard Short-Term Treasury ETF in Q1 2023, an estimated $15.1M increase.
  • Defender Capital's biggest Q1 2023 reduction was Axon Enterprise, cutting an estimated $5.01M.
  • Defender Capital fully exited Steel Connect, Inc. Common Stock in Q1 2023, selling an estimated $24.3K.
  • Defender Capital's ten largest holdings make up 92% of its $286M portfolio in Q1 2023.
  • Defender Capital opened 7 new positions and closed 1 in Q1 2023.
  • Defender Capital's portfolio value rose 16% quarter-over-quarter to $286M.

Based on Defender Capital's 13F filing for Q1 2023, filed 27 Apr 2023.